Imovax Polio

Inactivated poliovirus vaccine, the active ingredient in Imovax Polio, is a vaccine presented as an injectable solution for intramuscular, subcutaneous use. It is used to prevent poliomyelitis in individuals at risk of exposure.

GNH USA supplies Imovax Polio as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imovax Polio is a vaccine indicated for preventing poliovirus infection and its complications. It is employed in several clinical contexts: - Poliomyelitis (polio): Induces protective immunity against poliovirus types 1, 2 and 3 to prevent infection and disease. - Travel to endemic regions: Provides immunity before exposure for travelers visiting areas with circulating poliovirus. - Outbreak response: Used in mass vaccination campaigns to halt transmission during poliovirus outbreaks.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Fever: low‑grade temperature rise within 24‑48 hours. - Headache: transient headache post‑vaccination. - Malaise: general feeling of tiredness. - Muscle aches: mild myalgia.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Guillain‑Barré syndrome: rare autoimmune neuropathy. - Seizures: uncommon neurologic event. - High fever: temperature >39°C persisting beyond 48 hours. - Hypotension: sudden drop in blood pressure. - Severe allergic reaction to vaccine components.

Before administering Imovax Polio, consider the following precautions: - Pregnancy: consult a healthcare professional; benefits should outweigh potential risks. - Breastfeeding: use with caution; discuss with a physician. - Immunocompromised patients: monitor immune response, although the vaccine is inactivated. - Allergies: avoid if the patient has a known severe allergy to any vaccine component. - Administration technique: ensure correct intramuscular or subcutaneous injection using aseptic method. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Imovax Polio may interact with other agents that affect immune response.

Major Interactions (Avoid): - Live attenuated vaccines: avoid simultaneous administration; separate by at least 4 weeks. - Immunoglobulin therapy: may diminish vaccine‑induced immunity.

Moderate Interactions (Monitor Closely): - Antipyretics (e.g., acetaminophen): may mask fever, monitor for underlying reactions. - Corticosteroids: high‑dose therapy may blunt antibody production. - Blood products: transfusions shortly after vaccination could affect immune response. - Other vaccines: schedule appropriately to avoid interference.